Clue | Drug | % Correct |
---|---|---|
peptide hormone produced by beta cells in pancreas | insulin | 81%
|
antibiotic, discovered by Fleming | penicillin | 64%
|
Loop diuretic, inhibits NKCC2 in thick ascending limb of loop of Henle | furosemide | 48%
|
proton-pump inhibitor | omeprazole | 40%
|
blocks voltage-gated sodium channels, used as local anaesthetic or class I antidysrhythmic | lidocaine | 28%
|
NSAID, COX inhibitor | aspirin | 27%
|
H2 histamine receptor antagonist | ranitidine | 24%
|
potassium-sparing diuretic, aldosterone antagonist | spironolactone | 23%
|
clinically used cardiac glycoside, inhibits sodium/potassium ATPase in myocardium | digoxin | 21%
|
short-acting beta-2 agonist | salbutamol | 21%
|
osmotic diuretic | mannitol | 16%
|
class III antidysrhythmic agent, prolongs phase 3 of cardiac action potential | amiodarone | 14%
|
selective beta-1 adrenergic antagonist | atenolol | 14%
|
L-type calcium channel blocker | verapamil | 14%
|
diuretic - carbonic anhydrase inhibitor | Acetazolamide | 11%
|
non-selective beta adrenergic receptor blocker | propranolol | 11%
|
endogenous catecholamine, favours beta adrenergic receptors | adrenaline | 10%
|
potassium-sparing diuretic, blocks eNaC in DCT | amiloride | 8%
|
competitive inverse agonist of muscarinic cholinergic receptors, non-selective | atropine | 8%
|
predominantly beta-1 adrenergic agonist | dobutamine | 8%
|
prevents vesicular release of ACh, causing paralysis of muscles | botulinum toxin | 7%
|
CNS stimulant, indirectly acting sympathomimetic (IAS) | amphetamines | 6%
|
thiazide diuretic, inhibits sodium reabsorption at beginning of DCT | bendroflumethiazide | 6%
|
reversible AChE inhibitor, used to improve muscle tone in myasthenia gravis | neostigmine | 6%
|
binds to voltage-gated sodium channels, blocking passage of sodium ions, found in pufferfish | tetrodotoxin | 6%
|
depolarising neuromuscular blocker, acting on nicotinic receptors | suxamethonium | 5%
|
non-selective beta agonist | isoprenaline | 3%
|
non-depolarising blocking agent, competes for cholinergic receptors at motor end plates. | vecuronium | 3%
|
Class Ib antidysrhythmic, used in treatment of some forms of long QT syndrome | mexiletine | 1%
|
cardiac glycoside not clinically used, historically used in poison arrows | ouabain | 1%
|
nicotinic cholinergic receptor antagonist | tubocurarine | 1%
|
Copyright H Brothers Inc, 2008–2024
Contact Us | Go To Top | View Mobile Site